Investing in initial public offerings (IPOs) can be a lucrative opportunity for investors, and the Valiant Laboratories IPO is one that has caught the attention of many. With a strong reputation in the pharmaceutical industry, Valiant Laboratories is set to go public, and here’s all you need to know about its IPO pipeline.
The Valiant Laboratories IPO follows a well-defined pipeline, starting from the opening date and culminating in its listing on two major stock exchanges in India, NSE (National Stock Exchange) and BSE (Bombay Stock Exchange).
|Opening Date||27th Sep 2023||The IPO opens for subscription.|
|Closing Date||03rd Oct 2023||The IPO subscription period ends.|
|Allotment Date||06th Oct 2023||The process of allotting shares to investors begins.|
|Refund Date||09th Oct 2023||Excess money is refunded to investors if necessary.|
|Share Credit||10th Oct 2023||Shares allotted to investors are credited to their demat accounts.|
|Listing Date||11th Oct 2023||Valiant Laboratories’ shares are listed on NSE and BSE. Trading begins.|
About Valiant Laboratories
Valiant Laboratories, with a face value of ₹10 per share, is a distinguished name in the pharmaceutical sector. It boasts a rich history of producing high-quality pharmaceutical products and has successfully expanded its presence both nationally and internationally. Investors looking for a company with a solid track record and growth potential often find Valiant Laboratories appealing.
Retail Investors: A Significant Slice
One noteworthy aspect of the Valiant Laboratories IPO is the allocation for retail investors. A substantial 35% of the total shares are reserved for retail investors, underlining the company’s commitment to providing a fair chance to individual investors.